We further analyzed the differential expression, clinical prognosis, TME, tumor mutational burden (TMB), microsatellite instability status (MSI), drug sensitivity, and related signal pathways of ZFPM2-AS1 in 33 tumor types. The gene discussed is ZFPM2; the disease is neoplasm.